Search Results
RELATIVE BIOAVAILABILITY OF TWO FORMULATIONS OF THE SAME PROTON PUMP INHIBITOR AND HIGH POINT ESTIMATES ACHIEVED WITH DRUGS KNOWN TO EXHIBIT HIGH INTERINDIVIDUAL VARIANCES
15-21Eva Peterfai, David J. Edwards, Klaus Stoeckel, Rolf F. Tiggemann
RESEARCH ARTICLE Nobel Med 2006; 2(2): 15-21THE RELATION BETWEEN FIRST TRIMESTER SCREENING MARKERS AND MATERNAL FOLIC ACID AND VITAMIN B12 LEVELS
55-60Hakan Aytan, Ahmet Cantuğ Çalışkan, Fazlı Demirtürk, Tülay Aysal, Yeliz Hısım
RESEARCH ARTICLE Nobel Med 2011; 7(2): 55-60THE EFFECT OF LYCOPENE SUPPLEMENTATION ON CHRONIC OBSTRUCTIVE LUNG DISEASE
98-104Gamze Kırkıl, Mehmet Hamdi Muz, Enver Sancaktar, Dilara Kaman, Kazım Şahin, Ömer Küçük
RESEARCH ARTICLE Nobel Med 2012; 8(3): 98-104BIOEQUIVALENCE STUDY OF A FIXED DOSE COMBINATION OF IRBESARTAN/AMLODIPINE/HYDROCHLOROTHIAZIDE FILM COATED TABLET MANUFACTURED IN TURKEY
24-31Abdullah Uslu, İlksen Dikmen, Mustafa Köktürk, Serdar Ünlü, Seda Ünsalan, İclal Çakıcı, Sami Eren, Berrak Kılınç, Onursal Sağlam, Muradiye Nacak, Ömer Ocak
RESEARCH ARTICLE Nobel Med 2014; 10(3): 24-31FASTING AND FED BIOEQUIVALENCE STUDIES OF ETODOLAC SUSTAINED RELEASE TABLETS MANUFACTURED IN TURKEY IN HEALTHY VOLUNTEERS
53-59Abdullah Uslu, İlksen Dikmen, Seda Ünsalan, Berrak Kılınç, Onursal Sağlam, Aydın Erenmemişoğlu, İclal Çakıcı, Ömer Ocak
RESEARCH ARTICLE Nobel Med 2016; 12(2): 53-59